Cargando…

Investigational Anti–Atrial Fibrillation Pharmacology and Mechanisms by Which Antiarrhythmics Terminate the Arrhythmia: Where Are We in 2020?

Antiarrhythmic drugs remain the mainstay therapy for patients with atrial fibrillation (AF). A major disadvantage of the currently available anti-AF agents is the risk of induction of ventricular proarrhythmias. Aiming to reduce this risk, several atrial-specific or -selective ion channel block appr...

Descripción completa

Detalles Bibliográficos
Autor principal:	Burashnikov, Alexander
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Journal of Cardiovascular Pharmacology 2020
Materias:	Drugs in the Pipeline - Invited Review Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7641178/ https://www.ncbi.nlm.nih.gov/pubmed/33165131 http://dx.doi.org/10.1097/FJC.0000000000000892

Ejemplares similares

Inotropes and Inodilators for Acute Heart Failure: Sarcomere Active Drugs in Focus
por: Nagy, László, et al.
Publicado: (2014)

Targeting β(3)-Adrenergic Receptors in the Heart: Selective Agonism and β-Blockade
por: Cannavo, Alessandro, et al.
Publicado: (2017)

Levosimendan in Acute and Advanced Heart Failure: An Appraisal of the Clinical Database and Evaluation of Its Therapeutic Applications
por: Altenberger, Johann, et al.
Publicado: (2018)

Use of Levosimendan in Cardiac Surgery: An Update After the LEVO-CTS, CHEETAH, and LICORN Trials in the Light of Clinical Practice
por: Guarracino, Fabio, et al.
Publicado: (2018)

FDA review times for new drugs in ophthalmology
por: Carpenter, Michelle A., et al.
Publicado: (2020)

Five variables that rule your life – Home mortgage and biostatistical power
por: Novack, Gary D.
Publicado: (2020)

Repurposing medications
por: Novack, Gary D.
Publicado: (2021)

What is an adequate and well controlled study?
por: Novack, Gary D.
Publicado: (2021)

Expedited regulatory product approval in the time of COVID-19
por: Novack, Gary D.
Publicado: (2022)

Compounded medications for ocular surface disease
por: Lee, Edward H., et al.
Publicado: (2021)

Atrial Fibrillation Induced by Anticancer Drugs and Underling Mechanisms
por: Burashnikov, Alexander
Publicado: (2021)

Phase 1B, Randomized, Double-Blinded, Dose Escalation, Single-Center, Repeat Dose Safety and Pharmacodynamics Study of the Oral NLRP3 Inhibitor Dapansutrile in Subjects With NYHA II–III Systolic Heart Failure
por: Wohlford, George F., et al.
Publicado: (2021)

Special features of RAD Sequencing data: implications for genotyping
por: Davey, John W, et al.
Publicado: (2013)

Pulmonary Delivery of Antiarrhythmic Drugs for Rapid Conversion of New-Onset Atrial Fibrillation
por: Verrier, Richard L., et al.
Publicado: (2020)

Emerging Antiarrhythmic Drugs for Atrial Fibrillation
por: Saljic, Arnela, et al.
Publicado: (2022)

Mortality and ventricular arrhythmias in patients with atrial fibrillation on sotalol
por: Lenhoff, H, et al.
Publicado: (2023)

EST Pipeline System: Detailed and Automated EST Data Processing and Mining
por: Xu, Hao, et al.
Publicado: (2003)

When should we discontinue antiarrhythmic therapy for atrial fibrillation after abdominal surgery?
por: Pagano, Gennaro, et al.
Publicado: (2013)

Antiarrhythmic drugs for atrial fibrillation: Imminent impulses are emerging
por: Dan, Gheorghe-Andrei, et al.
Publicado: (2018)

Oral Anticoagulation and Antiarrhythmic Drug Therapy for Atrial Fibrillation
por: Reiffel, James A.
Publicado: (2018)

Biology Past and Biology Future: Where have we been and where are we going
Publicado: (2013)

Drugs for improving esophageal mucosa defense: where are we now and where are we going?
por: Savarino, Edoardo, et al.
Publicado: (2017)

Pharmacological treatments for PTSD: where are we in 2020?
por: Bui, Eric
Publicado: (2021)

Do we always need anticoagulation before cardioversion of atrial fibrillation in ladies?
por: Görenek, Bülent, et al.
Publicado: (2016)

Clinical application of virtual antiarrhythmic drug test using digital twins in patients who recurred atrial fibrillation after catheter ablation
por: Hwang, T, et al.
Publicado: (2023)

Association between specific antiarrhythmic drug prescription in the post-procedural blanking period and recurrent atrial arrhythmias after catheter ablation for atrial fibrillation
por: Malladi, Chaitanya L., et al.
Publicado: (2021)

Which antiarrhythmic drug to choose after electrical cardioversion: A study on non-valvular atrial fibrillation patients
por: Gwag, Hye Bin, et al.
Publicado: (2018)

Dental genetics in Brazil: Where we are
por: Casado, Priscila L., et al.
Publicado: (2018)

Atrial fibrillation
por: Munger, Thomas M., et al.
Publicado: (2014)

Prior antiarrhythmic drug use and the outcome of atrial fibrillation ablation
por: Winkle, Roger A., et al.
Publicado: (2012)

Pleiotropic Effects of Antiarrhythmic Agents: Dronedarone in the Treatment of Atrial Fibrillation
por: Heijman, Jordi, et al.
Publicado: (2013)

Computational Modeling for Antiarrhythmic Drugs for Atrial Fibrillation According to Genotype
por: Hwang, Inseok, et al.
Publicado: (2021)

Advancing global change biology through experimental manipulations: Where have we been and where might we go?
por: Hanson, Paul J., et al.
Publicado: (2019)

Cardiac Arrhythmias and Antiarrhythmic Drugs: An Autophagic Perspective
por: van Bavel, Joanne J. A., et al.
Publicado: (2018)

Stroke Prevention in Atrial Fibrillation: Where are We Now?
por: Ahmad, Yousif, et al.
Publicado: (2012)

The progress in optic nerve regeneration, where are we?
por: Shum, Jennifer Wei Huen, et al.
Publicado: (2016)

Point-of-care screening for atrial fibrillation: Where are we, and where do we go next?
por: Ashburner, Jeffrey M., et al.
Publicado: (2021)

Efficacy of class III antiarrhythmics and magnesium combination therapy for atrial fibrillation
por: Wang, Amy
Publicado: (2012)

Time‐dependent antiarrhythmic effects of flecainide on induced atrial fibrillation in horses
por: Carstensen, Helena, et al.
Publicado: (2018)

Knots to untie: anticoagulant and antiarrhythmic therapy after ablation for atrial fibrillation
por: Stazi, Filippo
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_a501lcohdrafgh1mt1apvco7o6